BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32596862)

  • 1. Downregulation of low-density lipoprotein receptor class A domain-containing protein 4 (Ldlrad4) in the liver of rats treated with nongenotoxic hepatocarcinogen to induce transforming growth factor β signaling promoting cell proliferation and suppressing apoptosis in early hepatocarcinogenesis.
    Ito Y; Nakajima K; Masubuchi Y; Kikuchi S; Okano H; Saito F; Akahori Y; Jin M; Yoshida T; Shibutani M
    J Appl Toxicol; 2020 Nov; 40(11):1467-1479. PubMed ID: 32596862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression Characteristics of Genes Hypermethylated and Downregulated in Rat Liver Specific to Nongenotoxic Hepatocarcinogens.
    Ito Y; Nakajima K; Masubuchi Y; Kikuchi S; Saito F; Akahori Y; Jin M; Yoshida T; Shibutani M
    Toxicol Sci; 2019 May; 169(1):122-136. PubMed ID: 30690589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between PTEN/Akt2 and TGFbeta signaling involving EGF receptor down-regulation during the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model.
    Taniai E; Kawai M; Dewa Y; Nishimura J; Harada T; Saegusa Y; Matsumoto S; Takahashi M; Mitsumori K; Shibutani M
    Cancer Sci; 2009 May; 100(5):813-20. PubMed ID: 19309364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of UBE2E2 in rat liver cells after hepatocarcinogen treatment facilitates cell proliferation and slowing down of DNA damage response in GST-P-expressing preneoplastic lesions.
    Mizukami S; Watanabe Y; Saegusa Y; Nakajima K; Ito Y; Masubuchi Y; Yoshida T; Shibutani M
    Toxicol Appl Pharmacol; 2017 Nov; 334():207-216. PubMed ID: 28899750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of Smad-dependent signaling for growth of GST-P-positive lesions from the early stage in a rat two-stage hepatocarcinogenesis model.
    Ichimura R; Mizukami S; Takahashi M; Taniai E; Kemmochi S; Mitsumori K; Shibutani M
    Toxicol Appl Pharmacol; 2010 Aug; 246(3):128-40. PubMed ID: 20423715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppression effects of bilberry extracts and enzymatically modified isoquercitrin in early preneoplastic liver cell lesions induced by piperonyl butoxide promotion in a two-stage rat hepatocarcinogenesis model.
    Hara S; Morita R; Ogawa T; Segawa R; Takimoto N; Suzuki K; Hamadate N; Hayashi SM; Odachi A; Ogiwara I; Shibusawa S; Yoshida T; Shibutani M
    Exp Toxicol Pathol; 2014 Aug; 66(5-6):225-34. PubMed ID: 24680176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of epigenetically downregulated Tmem70 and Ube2e2 in rat liver after 28-day treatment with hepatocarcinogenic thioacetamide showing gene product downregulation in hepatocellular preneoplastic and neoplastic lesions produced by tumor promotion.
    Mizukami S; Yafune A; Watanabe Y; Nakajima K; Jin M; Yoshida T; Shibutani M
    Toxicol Lett; 2017 Jan; 266():13-22. PubMed ID: 27914986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruptive cell cycle regulation involving epigenetic downregulation of Cdkn2a (p16(Ink4a)) in early-stage liver tumor-promotion facilitating liver cell regeneration in rats.
    Tsuchiya T; Wang L; Yafune A; Kimura M; Ohishi T; Suzuki K; Mitsumori K; Shibutani M
    Toxicology; 2012 Sep; 299(2-3):146-54. PubMed ID: 22659510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
    Fujii Y; Segawa R; Kimura M; Wang L; Ishii Y; Yamamoto R; Morita R; Mitsumori K; Shibutani M
    Chem Biol Interact; 2013 Sep; 205(2):108-18. PubMed ID: 23830814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of TMEM70 in Rat Liver Cells After Hepatocarcinogen Treatment Related to the Warburg Effect in Hepatocarcinogenesis Producing GST-P-Expressing Proliferative Lesions.
    Mizukami S; Watanabe Y; Nakajima K; Hasegawa-Baba Y; Jin M; Yoshida T; Shibutani M
    Toxicol Sci; 2017 Sep; 159(1):211-223. PubMed ID: 28903497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of multiple cell cycle aberrations in early preneoplastic liver cell lesions by tumor promotion with thioacetamide in a two-stage rat hepatocarcinogenesis model.
    Kimura M; Fujii Y; Yamamoto R; Yafune A; Hayashi SM; Suzuki K; Shibutani M
    Exp Toxicol Pathol; 2013 Nov; 65(7-8):979-88. PubMed ID: 23474136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of 1,3-dichloropropene-induced rat liver carcinogenesis.
    Klaunig JE; Gehen SC; Wang Z; Klein PJ; Billington R
    Toxicol Sci; 2015 Jan; 143(1):6-15. PubMed ID: 25354764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of enzymatically modified isoquercitrin on preneoplastic liver cell lesions induced by thioacetamide promotion in a two-stage hepatocarcinogenesis model using rats.
    Fujii Y; Kimura M; Ishii Y; Yamamoto R; Morita R; Hayashi SM; Suzuki K; Shibutani M
    Toxicology; 2013 Mar; 305():30-40. PubMed ID: 23318833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter-region hypermethylation and expression downregulation of Yy1 (Yin yang 1) in preneoplastic liver lesions in a thioacetamide rat hepatocarcinogenesis model.
    Abe H; Ogawa T; Wang L; Kimura M; Tanaka T; Morita R; Yoshida T; Shibutani M
    Toxicol Appl Pharmacol; 2014 Nov; 280(3):467-74. PubMed ID: 25151969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of nongenotoxic and genotoxic carcinogens on the preneoplastic lesions in the rat liver.
    Kim DJ; Lee KK; Hong JT
    Arch Pharm Res; 1998 Aug; 21(4):363-9. PubMed ID: 9875460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential responses on energy metabolic pathway reprogramming between genotoxic and non-genotoxic hepatocarcinogens in rat liver cells.
    Ito Y; Nakajima K; Masubuchi Y; Kikuchi S; Saito F; Akahori Y; Jin M; Yoshida T; Shibutani M
    J Toxicol Pathol; 2019 Oct; 32(4):261-274. PubMed ID: 31719753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of apoptosis revealed by laser microdissection and cDNA microarray analysis of related genes in rat liver preneoplastic lesions.
    Ogawa K; Asamoto M; Suzuki S; Tsujimura K; Shirai T
    Med Mol Morphol; 2005 Mar; 38(1):23-9. PubMed ID: 16158176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of selection of liver nodules initiated with N-nitrosodiethylamine and promoted with nodularin injections in fischer 344 male rats by reciprocal expression of transforming growth factor-beta1 and its receptors.
    Lim IK; Park SC; Song KY; Park TJ; Lee MS; Kim SJ; Hyun BH
    Mol Carcinog; 1999 Oct; 26(2):83-92. PubMed ID: 10506752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
    Mu X; Pradere JP; Affò S; Dapito DH; Friedman R; Lefkovitch JH; Schwabe RF
    Gastroenterology; 2016 Mar; 150(3):720-33. PubMed ID: 26627606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial prohibitins and septin 9 are implicated in the onset of rat hepatocarcinogenesis.
    Kakehashi A; Ishii N; Shibata T; Wei M; Okazaki E; Tachibana T; Fukushima S; Wanibuchi H
    Toxicol Sci; 2011 Jan; 119(1):61-72. PubMed ID: 20935162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.